Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vi polysaccharide vaccine (PT Bio Farma)
- Development stage
- Unknown
- Lead developer
- Bio Farma
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The Vi polysaccharide vaccine produced by PT Bio Farma is a monovalent subunit vaccine indicated for active immunization against typhoid fever caused by Salmonella enterica serovar Typhi. It consists of purified Vi capsular polysaccharide, a surface antigen of the bacterium that induces a T-cell independent immune response, leading to the production of protective IgG antibodies. This vaccine is typically administered as a single intramuscular injection and is approved for use in adults and children aged 2 years and older. In clinical research, PT Bio Farma has utilized this established vaccine as a reference comparator in trials evaluating the safety and immunogenicity of their next-generation Vi-DT typhoid conjugate vaccine (Bio-TCV).
- Other names
- Typhoid Vi polysaccharide vaccineViPS vaccineVi polysaccharide vaccine
02
Targets
Vi antigen (Vi capsular polysaccharide)
Beyond the preview
Go deeper on Vi polysaccharide vaccine (PT Bio Farma).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vi polysaccharide vaccine (PT Bio Farma).